FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4225768052> ?p ?o ?g. }

• W4225768052 endingPage "1759720X2210914" @default.
• W4225768052 startingPage "1759720X2210914" @default.
• W4225768052 abstract "Despite improved care for rheumatoid arthritis (RA) patients, many still experience treatment failure with biologic disease-modifying antirheumatic drugs (bDMARDs) or targeted synthetic DMARDs [tsDMARDs; typically Janus kinase inhibitors (JAKi)], and eventually switch to other agents. We compared the efficacy of a second tumor necrosis factor inhibitor (TNFi) and non-TNF-targeted treatment as the second-line treatment in patients showing an insufficient response to the first TNFi.Patients were included if they had received at least one prescription for a TNFi, and at least one follow-up prescription for a second TNFi or non-TNF-targeted treatment after discontinuation of the first drug. In total, 209 patients were analyzed, including 69 with a second TNFi and 140 with a non-TNF-targeted treatment (106 non-TNFi biologics and 34 JAKi). Cox regression was used to estimate the hazard ratio (HR) for discontinuation.The mean follow-up period after switching was 28.0 (range: 0-80) months and 24.4% of the 209 patients switched or discontinued the second drug. In multivariate Cox proportional hazard analysis, the non-TNF-targeted treatment group had a lower likelihood of discontinuing their treatment than the second TNFi group [HR = 0.326, 95% confidence interval (CI): 0.170-0.626, p = 0.001]. When analyzed separately, the risk of discontinuation was significantly lower in both the non-TNFi biologic (HR = 0.318, 95% CI: 0.160-0.633, p = 0.001) and JAKi (HR = 0.356, 95% CI: 0.129-0.980, p = 0.046) groups than in the second TNFi group.Our study supported switching to a non-TNF-targeted treatment instead of TNF cycling in patients with RA showing an inadequate response to initial TNFi." @default.
• W4225768052 created "2022-05-05" @default.
• W4225768052 creator A5024843746 @default.
• W4225768052 creator A5036999579 @default.
• W4225768052 creator A5039404576 @default.
• W4225768052 creator A5040628398 @default.
• W4225768052 creator A5053652332 @default.
• W4225768052 creator A5054429863 @default.
• W4225768052 date "2022-01-01" @default.
• W4225768052 modified "2023-10-16" @default.
• W4225768052 title "Comparison of the efficacy and risk of discontinuation between non-TNF-targeted treatment and a second TNF inhibitor in patients with rheumatoid arthritis after first TNF inhibitor failure" @default.
• W4225768052 cites W1874236485 @default.
• W4225768052 cites W1877953244 @default.
• W4225768052 cites W1966439074 @default.
• W4225768052 cites W1994621214 @default.
• W4225768052 cites W2024644107 @default.
• W4225768052 cites W2046628605 @default.
• W4225768052 cites W2051986755 @default.
• W4225768052 cites W2054989797 @default.
• W4225768052 cites W2059796825 @default.
• W4225768052 cites W2084872302 @default.
• W4225768052 cites W2098896429 @default.
• W4225768052 cites W2105969691 @default.
• W4225768052 cites W2106207910 @default.
• W4225768052 cites W2110177517 @default.
• W4225768052 cites W2113131907 @default.
• W4225768052 cites W2114308202 @default.
• W4225768052 cites W2124670599 @default.
• W4225768052 cites W2128952811 @default.
• W4225768052 cites W2133915381 @default.
• W4225768052 cites W2134704116 @default.
• W4225768052 cites W2136215457 @default.
• W4225768052 cites W2142004396 @default.
• W4225768052 cites W2152721471 @default.
• W4225768052 cites W2404262996 @default.
• W4225768052 cites W2523119278 @default.
• W4225768052 cites W2554322291 @default.
• W4225768052 cites W2558871347 @default.
• W4225768052 cites W2594517300 @default.
• W4225768052 cites W2734111082 @default.
• W4225768052 cites W2808428727 @default.
• W4225768052 cites W2912182619 @default.
• W4225768052 cites W2922151066 @default.
• W4225768052 cites W2946341504 @default.
• W4225768052 cites W2971217817 @default.
• W4225768052 cites W3016333849 @default.
• W4225768052 cites W3017389231 @default.
• W4225768052 cites W3021810212 @default.
• W4225768052 cites W3026155297 @default.
• W4225768052 cites W3036923704 @default.
• W4225768052 cites W3158108145 @default.
• W4225768052 cites W3171954900 @default.
• W4225768052 cites W4210968471 @default.
• W4225768052 cites W4232407672 @default.
• W4225768052 cites W4235790631 @default.
• W4225768052 doi "https://doi.org/10.1177/1759720x221091450" @default.
• W4225768052 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/35464808" @default.
• W4225768052 hasPublicationYear "2022" @default.
• W4225768052 type Work @default.
• W4225768052 citedByCount "2" @default.
• W4225768052 countsByYear W42257680522023 @default.
• W4225768052 crossrefType "journal-article" @default.
• W4225768052 hasAuthorship W4225768052A5024843746 @default.
• W4225768052 hasAuthorship W4225768052A5036999579 @default.
• W4225768052 hasAuthorship W4225768052A5039404576 @default.
• W4225768052 hasAuthorship W4225768052A5040628398 @default.
• W4225768052 hasAuthorship W4225768052A5053652332 @default.
• W4225768052 hasAuthorship W4225768052A5054429863 @default.
• W4225768052 hasBestOaLocation W42257680521 @default.
• W4225768052 hasConcept C126322002 @default.
• W4225768052 hasConcept C143998085 @default.
• W4225768052 hasConcept C17991360 @default.
• W4225768052 hasConcept C207103383 @default.
• W4225768052 hasConcept C2776233030 @default.
• W4225768052 hasConcept C2777575956 @default.
• W4225768052 hasConcept C2778715236 @default.
• W4225768052 hasConcept C2778886723 @default.
• W4225768052 hasConcept C2779722408 @default.
• W4225768052 hasConcept C2780132546 @default.
• W4225768052 hasConcept C44249647 @default.
• W4225768052 hasConcept C50382708 @default.
• W4225768052 hasConcept C71924100 @default.
• W4225768052 hasConceptScore W4225768052C126322002 @default.
• W4225768052 hasConceptScore W4225768052C143998085 @default.
• W4225768052 hasConceptScore W4225768052C17991360 @default.
• W4225768052 hasConceptScore W4225768052C207103383 @default.
• W4225768052 hasConceptScore W4225768052C2776233030 @default.
• W4225768052 hasConceptScore W4225768052C2777575956 @default.
• W4225768052 hasConceptScore W4225768052C2778715236 @default.
• W4225768052 hasConceptScore W4225768052C2778886723 @default.
• W4225768052 hasConceptScore W4225768052C2779722408 @default.
• W4225768052 hasConceptScore W4225768052C2780132546 @default.
• W4225768052 hasConceptScore W4225768052C44249647 @default.
• W4225768052 hasConceptScore W4225768052C50382708 @default.
• W4225768052 hasConceptScore W4225768052C71924100 @default.
• W4225768052 hasFunder F4320310848 @default.
• W4225768052 hasFunder F4320321198 @default.
• W4225768052 hasLocation W42257680521 @default.

• next